
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
over 25 years ago
Introductionover 25 years ago
Cholesterol: Precursor to Many Lipid Disordersover 25 years ago
Lipid Management: Tools for Getting to the Goalover 25 years ago
Identifying All Suspects: Case Studiesover 25 years ago
Continuing Pharmacy/Nursing Education Quizover 25 years ago
Literature Review


